Intravenous Equipment Market - Global Forecast 2025-2032

Senior healthcare leaders are closely monitoring shifts in the intravenous equipment market as medical technology accelerates and care delivery evolves. With operational demands rising and care settings diversifying, effective market strategies and innovative procurement models are becoming essential.

Market Snapshot: Growth Trajectory in the Intravenous Equipment Market

The intravenous equipment market expanded from USD 13.24 billion in 2024 to USD 14.07 billion in 2025, recording a compound annual growth rate of 6.29%. Projections put the market at USD 21.59 billion by 2032. Growth is driven by increasing adoption of advanced infusion systems, investments in hospital infrastructure, and heightened patient safety requirements. As care shifts toward home and community settings, hospitals and providers are prioritizing products that enhance patient mobility and adaptability. Global regulatory developments are streamlining integration of new technologies, supporting smarter workflows and broadening the impact of intravenous solutions in clinical practice.

Scope & Segmentation of the Intravenous Equipment Market

• Product Types: Drip chambers, extension tubing, infusion sets, filters, cannulas (non winged and winged), catheters (central, peripheral, and peripherally inserted central), and a range of infusion pumps such as elastomeric, insulin, syringe, and volumetric types.
• End Users: Ambulatory care facilities, hospitals of all sizes and specialties, and home healthcare settings, each with distinct procurement needs based on patient load and care complexity.
• Applications: Suitable for anesthesia, pain management, oncology, nutrition therapy, and intensive or critical care, reflecting the broad clinical importance of intravenous solutions.
• Disposable vs. Reusable: Both disposable and reusable equipment options support sustainability goals and varying approaches to cost management across facilities.
• Portability: Includes portable and stationary systems designed for usage flexibility in both traditional inpatient and expanded outpatient environments.
• Material Types: Devices made from polyolefin, polyurethane, and polyvinyl chloride, ensuring both biocompatibility and alignment with different regional regulatory standards.
• Geographic Regions: Market intelligence covers major regions such as the Americas, Europe, Middle East, Africa, and Asia-Pacific, with deeper analysis of the United States, Brazil, Germany, United Kingdom, Saudi Arabia, China, India, and Australia.
• Key Companies: Strategic assessments include leading industry players: Becton, Dickinson and Company; Baxter International Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Terumo Corporation; ICU Medical; Smiths Medical; Nipro Corporation; Shenzhen Mindray Bio-Medical Electronics; Medtronic plc.

Key Takeaways for Senior Decision-Makers

• Intravenous delivery systems continue to underpin therapy administration and patient satisfaction across care settings, influencing overall workflow efficiency and the standard of care.
• Integration of smart technologies, including advanced pumps and digital monitoring systems, delivers better clinical insight and supports real-time decision-making by multidisciplinary teams.
• Recent safety enhancements, such as closed infusion devices and antimicrobial coatings, make compliance with stringent hygiene and infection-prevention regulations more achievable across regions.
• Shift toward mobile and user-friendly intravenous systems is reshaping procurement approaches to support expanding home-based and outpatient care models.
• Cross-functional collaboration—among clinicians, biomedical engineers, and product developers—is accelerating the customization of devices, ensuring responsiveness to evolving clinical demands and compliance mandates.
• Continuous monitoring of supply chain resilience, coupled with strategic material choices, helps organizations meet environmental benchmarks and mitigate risks from market or regulatory disruptions.

Tariff Impact: 2025 Trade Developments Affecting the Intravenous Equipment Market

New tariffs implemented in the United States for 2025 are compelling manufacturers to reassess sourcing, increase automation, and strengthen ties with local suppliers to address rising production costs. Distributors and healthcare organizations are renegotiating procurement contracts and widening supplier networks to ensure reliable access and business continuity. Effective supply management relies on close alignment among regulators, industry coalitions, and manufacturers to uphold product quality throughout changing trade conditions.

Methodology & Data Sources

This analysis is based on primary interviews with clinicians, procurement executives, and biomedical engineers, along with secondary research from medical journals, regulatory entities, and industry databases. Expert panels and advisory workshops further validate the strategic recommendations for decision-makers in the intravenous equipment market.

Why This Report Matters

• Empowers healthcare leaders to enhance sourcing and supply chain strategies while safeguarding compliance and adaptive capability during industry transitions.
• Delivers actionable insights into the influence of technological trends, regional market dynamics, and emerging innovations on equipment procurement and deployment.
• Supports proactive risk management and identifies new pathways for sustainable market growth in a regulated and rapidly evolving healthcare environment.

Conclusion

The intravenous equipment market will be shaped by ongoing innovation, regulatory progress, and the expansion of flexible care models. Organizations leveraging advanced technology and strategic collaborations will be best prepared to address future care delivery challenges.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.